RxDoctor Payments Data

Deisy Guzman

Family · Hialeah, FLNPI 1518639376

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 150 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 22.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,242 and has fallen 50.1% since, to $620 in 2025.

$2,873in general payments, 2019–2025

Across 150 payments — averaging $19.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$654
  • Novo Nordisk$338
  • Lilly USA, LLC$337
  • Bayer$308
  • GSK$208
  • Amgen$180
  • plus $848 from 15 others

What the payments were for

  • Food & beverage$2,873100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,873 in reported general payments places this provider in the 85th percentile of 14,618 family providers in Florida.

See all family providers in Florida →

Other family in Hialeah

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →